Study Assessing the Efficacy and Safety of Alpelisib + Nab-paclitaxel in Subjects With Advanced TNBC Who Carry Either a PIK3CA Mutation or Have PTEN Loss

~24 mi. (Rionero in Vulture, Italy, +170 more cities)

Novartis Investigative Site

ER Negative, +4 more biomarkers

Breast Carcinoma

alpelisib, +1 more drug

chemotherapy, +1 more type

A Study of Venetoclax and Dexamethasone Compared With Pomalidomide and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma

~24 mi. (Rionero in Vulture, Italy, +156 more cities)

Irccs-Crob /Id# 170955

IGH-CCND1 Fusion, +1 more biomarker

Multiple Myeloma

dexamethasone, +1 more drug

chemotherapy, +1 more type

Study of Oral Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations

~24 mi. (Rionero in Vulture, Italy, +120 more cities)

IRCCS Centro di Riferimento Oncologico di Basilicata

FGFR3 A391E, +9 more biomarkers

Urothelial Carcinoma

infigratinib

targeted therapy

A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy

~41 mi. (Avellino, Italy, +260 more cities)

AORN'S.G.Moscati; Oncologia

ERBB2 Amplification, +1 more biomarker

Invasive Breast Carcinoma

ado-trastuzumab emtansine, +1 more drug

immunotherapy, +1 more type

A Study of Trastuzumab Emtansine in Combination With Atezolizumab or Placebo as a Treatment for Participants With Human Epidermal Growth Factor 2 (HER2)-Positive and Programmed Death-ligand 1 (PD-L1)-Positive Locally Advanced (LABC) or Metastatic Breast Cancer (MBC)

~41 mi. (Avellino, Italy, +115 more cities)

Azienda Ospedaliera di Rilievo Nazionale e di Alta Specialita San Giuseppe Moscati

ERBB2 Amplification, +7 more biomarkers

Breast Carcinoma

ado-trastuzumab emtansine, +1 more drug

immunotherapy, +1 more type

Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants With Advanced/Metastatic Non-small Cell Lung Cancer

~41 mi. (Avellino, Italy, +151 more cities)

GSK Investigational Site

Non-Small Cell Lung Carcinoma

niraparib, +1 more drug

immunotherapy, +1 more type

A Study of Tiragolumab in Combination With Atezolizumab Compared With Placebo in Combination With Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung Cancer

~41 mi. (Avellino, Italy, +135 more cities)

Azienda Ospedaliera San Giuseppe Moscati

PD-L1 Expression (IC >= 10%), +1 more biomarker

Non-Small Cell Lung Carcinoma

atezolizumab, +1 more drug

immunotherapy

CONcurrent vs SEqueNTial Adjuvant Treatments in Early Breast Cancer

~41 mi. (Avellino, Italy, +64 more cities)

A.O. San Giuseppe Moscati

ER Positive, +1 more biomarker

Breast Carcinoma

anastrozole, +2 more drugs

hormone therapy

A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors

~41 mi. (Avellino, Italy, +118 more cities)

A.O. San Giuseppe Moscati

NTRK1 Fusion, +2 more biomarkers

Biliary Tract Carcinoma, +12 more conditions

larotrectinib

targeted therapy

Study of Cobolimab in Combination With Dostarlimab and Docetaxel in Advanced NSCLC Participants

~41 mi. (Avellino, Italy, +71 more cities)

GSK Investigational Site

Non-Small Cell Lung Carcinoma

cobolimab, +2 more drugs

chemotherapy, +1 more type

Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)

~50 mi. (Torrette, Italy, +158 more cities)

Azienda Ospedaliera Umberto I- Torrette ( Site 1009)

Non-Small Cell Lung Carcinoma

olaparib, +4 more drugs

chemotherapy, +3 more types

A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer

~60 mi. (Napoli, Italy, +192 more cities)

Istituto Nazionale Tumori IRCCS Fondazione Pascale

ER Positive, +1 more biomarker

Breast Carcinoma

abemaciclib, +1 more drug

hormone therapy, +1 more type